Rajiv Desilva

Rajiv De Silva is the Chairman of the Board of Directors at Covis Pharma, a global specialty pharmaceutical company.13 He is a seasoned business leader with extensive experience in the biopharmaceutical sector, having spent 25 years in the industry, including eight years at the executive level in publicly traded healthcare companies.1

De Silva's career highlights include:

1. President, CEO, and Director of Endo International Plc from 2013 to 2016.12
2. President of Valeant Pharmaceuticals (now Bausch Health) from 2010 to 2013, and COO of its Specialty Pharmaceuticals business from 2009 to 2013.12
3. Multiple leadership positions at Novartis AG from 2003 to 2008, including President of Novartis Pharmaceuticals Canada.13
4. Started his career at McKinsey in 1995, rising to Partner in the Pharmaceuticals and Medical Products Practice.1

Currently, De Silva is also the Managing Partner of Asiri Advisors and co-founder of Asiri Skincare, a privately held company focused on topical consumer therapeutic skincare products.13

De Silva's educational background includes:

• BSE with Honors from Princeton University
• MS from Stanford University
• MBA with Distinction from the Wharton School at the University of Pennsylvania12

His appointment as Chairman of Covis Pharma in 2020 coincided with the company's partnership with Apollo, providing a foundation for global expansion through acquisitions, organic growth, and product development.14